je.st
news
FDA approves J&J drug for advanced multiple myeloma
2015-11-16 23:13:12| Biotech - Topix.net
REUTERS: U.S. regulators have approved an experimental treatment from Johnson & Johnson that may offer hope to multiple myeloma patients who have run out of other options against the blood cancer. The U.S. Food and Drug Administration on Monday said it had approved Darzalex for patients who had already undergone at least three prior standard treatments for the cancer, which affects infection-fighting plasma cells that reside in the bone marrow.
Tags: advanced
multiple
drug
fda
Category:Biotechnology and Pharmaceuticals